Crewe Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $456K | Buy |
2,459
+15
| +0.6% | +$2.78K | 0.06% | 96 |
|
|
2025
Q1 | $512K | Sell |
2,444
-212
| -8% | -$44.4K | 0.07% | 77 |
|
|
2024
Q4 | $472K | Sell |
2,656
-756
| -22% | -$134K | 0.07% | 79 |
|
|
2024
Q3 | $674K | Buy |
3,412
+19
| +0.6% | +$3.75K | 0.08% | 68 |
|
|
2024
Q2 | $582K | Buy |
3,393
+199
| +6% | +$34.1K | 0.07% | 94 |
|
|
2024
Q1 | $582K | Buy |
+3,194
| New | +$582K | 0.07% | 88 |
|
|
2023
Q3 | – | Sell |
-2,642
| Closed | -$356K | – | 583 |
|
|
2023
Q2 | $356K | Sell |
2,642
-665
| -20% | -$89.6K | 0.05% | 98 |
|
|
2023
Q1 | $527K | Sell |
3,307
-13
| -0.4% | -$2.07K | 0.08% | 82 |
|
|
2022
Q4 | $537K | Buy |
3,320
+1,026
| +45% | +$166K | 0.09% | 74 |
|
|
2022
Q3 | $308K | Buy |
2,294
+863
| +60% | +$116K | 0.06% | 104 |
|
|
2022
Q2 | $219K | Buy |
1,431
+1,331
| +1,331% | +$204K | 0.05% | 119 |
|
|
2022
Q1 | $16K | Hold |
100
| – | – | ﹤0.01% | 315 |
|
|
2021
Q4 | $14K | Buy |
100
+17
| +20% | +$2.38K | ﹤0.01% | 297 |
|
|
2021
Q3 | $9K | Hold |
83
| – | – | ﹤0.01% | 271 |
|
|
2021
Q2 | $9K | Hold |
83
| – | – | ﹤0.01% | 283 |
|
|
2021
Q1 | $9K | Hold |
83
| – | – | ﹤0.01% | 295 |
|
|
2020
Q4 | $9K | Sell |
83
-52
| -39% | -$5.64K | ﹤0.01% | 273 |
|
|
2020
Q3 | $12K | Buy |
+135
| New | +$12K | 0.01% | 225 |
|
|
2018
Q4 | – | Sell |
-75
| Closed | -$7K | – | 226 |
|
|
2018
Q3 | $7K | Sell |
75
-150
| -67% | -$14K | 0.01% | 202 |
|
|
2018
Q2 | $21K | Sell |
225
-125
| -36% | -$11.7K | 0.02% | 172 |
|
|
2018
Q1 | $33K | Buy |
350
+348
| +17,400% | +$32.8K | 0.03% | 143 |
|
|
2017
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 267 |
|